Aktis Oncology Inc.

Contributing Author

Recent Articles by Aktis Oncology Inc.

Mar-30	Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY-2519 and Provides Business Updates and Full Year 2025 Financial Results AKTS +8.89% AKTS +8.16% GlobeNewswire
Feb-24	Aktis Oncology to Present at Upcoming March Investor Conferences AKTS GlobeNewswire
Feb-24	Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate AKTS GlobeNewswire
Jan-13	Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares AKTS GlobeNewswire